Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lai

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Breast Cancer Research : BCR|December 15, 2023
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR studyHan-Fang Cheng, Yi-Fang Tsai, Chun-Yu Liu, et al.
Cancers|September 28, 2023
Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue for Early Breast CancerChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Experimental Cell Research|May 20, 2023
Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer modelLing-Ming Tseng, Ka-Yi Lau, Ji-Lin Chen, et al.
Cell Surface (Amsterdam, Netherlands)|August 4, 2020
Assembly and disassembly of <i>Aspergillus fumigatus</i> conidial rodletsIsabel Valsecchi, Jennifer I Lai, Emmanuel Stephen-Victor, et al.
Cancer Treatment and Research Communications|March 26, 2025
A retrospective study to investigate the prevalence and describe the clinicopathological characteristics, treatments, and outcomes of HER2-low Breast Cancer in TaiwanKuo-Ting Lee, Po-Hsiang Huang, Chih-Yi Hsu, et al.
Journal for Immunotherapy of Cancer|April 3, 2020
<i>PRKDC</i>: new biomarker and drug target for checkpoint blockade immunotherapyKien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, et al.
ACS Nano|August 3, 2013
Non-antireflective scheme for efficiency enhancement of Cu(In,Ga)Se2 nanotip array solar cellsYu-Kuang Liao, Yi-Chung Wang, Yu-Ting Yen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2024
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH TrialKevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, et al.
Science Advances|October 24, 2020
Supramolecular nanosubstrate-mediated delivery system enables CRISPR-Cas9 knockin of hemoglobin beta gene for hemoglobinopathiesPeng Yang, Shih-Jie Chou, Jindian Li, et al.
Journal of Breast Cancer|July 6, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer ManagementJiun-I Lai, Chih-Chiang Hung, Chin-Yao Lin, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Breast Cancer Research : BCR|December 15, 2023
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR studyHan-Fang Cheng, Yi-Fang Tsai, Chun-Yu Liu, et al.
Cancers|September 28, 2023
Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue for Early Breast CancerChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Experimental Cell Research|May 20, 2023
Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer modelLing-Ming Tseng, Ka-Yi Lau, Ji-Lin Chen, et al.
Cell Surface (Amsterdam, Netherlands)|August 4, 2020
Assembly and disassembly of <i>Aspergillus fumigatus</i> conidial rodletsIsabel Valsecchi, Jennifer I Lai, Emmanuel Stephen-Victor, et al.
Cancer Treatment and Research Communications|March 26, 2025
A retrospective study to investigate the prevalence and describe the clinicopathological characteristics, treatments, and outcomes of HER2-low Breast Cancer in TaiwanKuo-Ting Lee, Po-Hsiang Huang, Chih-Yi Hsu, et al.
Journal for Immunotherapy of Cancer|April 3, 2020
<i>PRKDC</i>: new biomarker and drug target for checkpoint blockade immunotherapyKien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, et al.
ACS Nano|August 3, 2013
Non-antireflective scheme for efficiency enhancement of Cu(In,Ga)Se2 nanotip array solar cellsYu-Kuang Liao, Yi-Chung Wang, Yu-Ting Yen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2024
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH TrialKevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, et al.
Science Advances|October 24, 2020
Supramolecular nanosubstrate-mediated delivery system enables CRISPR-Cas9 knockin of hemoglobin beta gene for hemoglobinopathiesPeng Yang, Shih-Jie Chou, Jindian Li, et al.
Journal of Breast Cancer|July 6, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer ManagementJiun-I Lai, Chih-Chiang Hung, Chin-Yao Lin, et al.
Pageof 16